SG Americas Securities LLC Has $834,000 Stock Holdings in Tempus AI, Inc. (NASDAQ:TEM)

SG Americas Securities LLC grew its position in Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 56.6% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 17,279 shares of the company's stock after buying an additional 6,247 shares during the period. SG Americas Securities LLC's holdings in Tempus AI were worth $834,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in the business. Victory Capital Management Inc. bought a new position in Tempus AI during the 4th quarter worth approximately $216,000. Wells Fargo & Company MN raised its position in Tempus AI by 13.2% in the 4th quarter. Wells Fargo & Company MN now owns 2,384 shares of the company's stock valued at $80,000 after buying an additional 278 shares during the last quarter. SeaCrest Wealth Management LLC bought a new stake in shares of Tempus AI in the first quarter worth $535,000. ProShare Advisors LLC acquired a new position in shares of Tempus AI during the 4th quarter worth about $244,000. Finally, Avanza Fonder AB increased its position in shares of Tempus AI by 15.8% during the 1st quarter. Avanza Fonder AB now owns 41,005 shares of the company's stock worth $2,047,000 after purchasing an additional 5,591 shares during the last quarter. 24.22% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Tempus AI

In other Tempus AI news, EVP Andrew Polovin sold 17,552 shares of Tempus AI stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $63.43, for a total value of $1,113,323.36. Following the transaction, the executive vice president now directly owns 138,877 shares of the company's stock, valued at $8,808,968.11. The trade was a 11.22% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Wayne A.I. Frederick sold 3,000 shares of the company's stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $45.54, for a total transaction of $136,620.00. Following the transaction, the director now directly owns 26,514 shares of the company's stock, valued at approximately $1,207,447.56. This trade represents a 10.16% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 359,897 shares of company stock worth $23,880,283. 27.60% of the stock is currently owned by corporate insiders.

Tempus AI Trading Down 1.4%

Shares of TEM stock opened at $69.10 on Friday. The company has a 50-day simple moving average of $58.21 and a two-hundred day simple moving average of $52.66. The company has a debt-to-equity ratio of 2.45, a quick ratio of 1.56 and a current ratio of 1.71. Tempus AI, Inc. has a 52-week low of $22.89 and a 52-week high of $91.45. The company has a market capitalization of $11.96 billion and a price-to-earnings ratio of -8.86.

Tempus AI (NASDAQ:TEM - Get Free Report) last announced its quarterly earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share for the quarter, beating the consensus estimate of ($0.27) by $0.03. The company had revenue of $255.74 million during the quarter, compared to analysts' expectations of $248.13 million. Tempus AI had a negative return on equity of 533.21% and a negative net margin of 88.27%. Tempus AI's revenue for the quarter was up 75.4% on a year-over-year basis. Research analysts anticipate that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. BTIG Research began coverage on shares of Tempus AI in a research report on Monday, April 21st. They set a "buy" rating and a $60.00 price objective for the company. Bank of America boosted their price objective on shares of Tempus AI from $48.00 to $68.00 and gave the company a "neutral" rating in a research report on Tuesday, May 20th. Morgan Stanley raised their price objective on Tempus AI from $60.00 to $65.00 and gave the company an "overweight" rating in a report on Friday, May 9th. Wolfe Research downgraded Tempus AI from a "strong-buy" rating to a "hold" rating in a report on Wednesday, February 26th. Finally, William Blair reissued a "market perform" rating on shares of Tempus AI in a research report on Tuesday, February 25th. Six analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $63.42.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.